Test ID BLOD1732 ADAMTS13 Activity with Reflex Inhibitor Profile, Plasma
Useful For
Assisting with the diagnosis of immune or acquired thrombotic thrombocytopenic purpura
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
ADAMS | ADAMTS13 Activity Assay, P | Yes | Yes |
ADMI | ADAMTS13 Interpretation | No | Yes |
Specimen Type
Plasma Na CitOrdering Guidance
Order the profile when considering a diagnosis of immune thrombotic thrombocytopenic purpura (iTTP), also known as acquired thrombotic thrombocytopenic purpura (aTTP). This diagnosis should be considered in a patient presenting with hemolytic anemia and thrombocytopenia. In patients with known iTTP/aTTP, the profile (rather than the single order ADAMTS13 activity) should be ordered if wanting to monitor presence of ADAMTS13 inhibitor.
Shipping Instructions
Send both vials in the same shipping container.
Specimen Required
Patient Preparation: Fasting preferred
Collection Container/Tube: Light-blue top (3.2% sodium citrate)
Submission Container/Tube: Plastic vials
Specimen Volume: 2 mL in 2 plastic vials each containing 1 mL
Collection Instructions:
1. Specimen must be collected prior to replacement therapy.
2. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing
3. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.
4. Aliquot plasma (1 mL per aliquot) into 2 separate plastic vials, leaving 0.25 mL in the bottom of centrifuged vial.
5. Freeze plasma immediately (no longer than 4 hours after collection) at -20° C or, ideally, below -40° C.
Additional Information:
1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.
2. Each coagulation assay requested should have its own vial.
Specimen Stability Information: Frozen 2 years
Specimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Special Instructions
Day(s) Performed
Monday through Friday, Sunday
Report Available
1 to 3 daysMethod Name
ADAMS, ADMB: Fluorescence Resonance Energy Transfer (FRET)
ADMI, AADAM: Technical Interpretation
Reporting Name
ADAMTS13 Act w/Inhibitor Prof, PPerforming Laboratory
Mayo Clinic Laboratories in RochesterSecondary ID
620815CPT Code Information
85397
85335 (if appropriate)
Reference Values
ADAMTS13 Activity Assay
≥70%
Although not verified, the pediatric (<1 years old) reference range could be similar to or lower than that of adults.
ADAMTS13 Inhibitor Titer
<0.5 BU
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Testing Algorithm
Testing begins with the ADAMTS13 activity assay to evaluate the percent activity. If the ADAMTS13 activity is less than 30%, the inhibitor titer and ADAMTS13 profile interpretation will be performed.
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
ADMB | ADAMTS13 Inhibitor Titer, P | No | No |
AADAM | ADAMTS13 Profile Interpretation | No | No |
Forms
1. If not ordering electronically, complete, print, and send one of the following with the specimen:
-Renal Diagnostics Test Request (T830)
-Coagulation Test Request (T753)
2. Coagulation Patient Information (T675)
SANFORD LABORATORY INTERFACE BUILD INFORMATION
Result Code | Result Code Description |
---|---|
27982 | ADAMTS13 Activity |
27983 | Interpretation |
27984 | ADAMTS13 Interpretation |
27985 | ADAMTS13 Interpretation |
27986 | ADAMTS13 Inhibitor Titer |
27987 | ADAMTS13 Profile Interpretation |
27988 | ADAMTS13 Profile Interpretation |